NMS-P118
CAS No. 1262417-51-5
NMS-P118( NMS-P118 | NMS-P 118 | NMS P118 )
Catalog No. M11093 CAS No. 1262417-51-5
A potent and highly selective PARP-1 inhibitor with Kd of 9 nM; shows 150-fold selectivity for PARP-1 over PARP-2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 92 | In Stock |
|
| 5MG | 93 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 297 | In Stock |
|
| 50MG | 458 | In Stock |
|
| 100MG | 666 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameNMS-P118
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent and highly selective PARP-1 inhibitor with Kd of 9 nM; shows 150-fold selectivity for PARP-1 over PARP-2.
-
DescriptionA potent and highly selective PARP-1 inhibitor with Kd of 9 nM; shows 150-fold selectivity for PARP-1 over PARP-2; exhibits excellent ADME and pharmacokinetic profiles and high efficacy in MDA-MB-436 and Capan-1 xenograft models; orally available.Breast Cancer Preclinical.
-
In Vitro——
-
In Vivo——
-
SynonymsNMS-P118 | NMS-P 118 | NMS P118
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP
-
Research AreaCancer
-
IndicationBreast Cancer
Chemical Information
-
CAS Number1262417-51-5
-
Formula Weight395.4187
-
Molecular FormulaC20H24F3N3O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: 16 mg/mL
-
SMILESO=C(C1=CC(F)=CC(CN2C3CCN(C4CCC(F)(F)CC4)CC3)=C1C2=O)N
-
Chemical Name1H-Isoindole-4-carboxamide, 2-[1-(4,4-difluorocyclohexyl)-4-piperidinyl]-6-fluoro-2,3-dihydro-3-oxo-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Papeo G, et al. J Med Chem. 2015 Sep 10;58(17):6875-98.
molnova catalog
related products
-
AZD-9574
AZD-9574 is a selective inhibitor of PARP1 at the sites of SSBs. AZD-9574 exhibits anti-cancer activities and can be used in studies about HRD+ breast cancer and advanced solid malignancies.
-
TIQ-A
TIQ-A is a PARP1 inhibitor which involved in DNA single-strand break repair via the base excision repair pathway. PARP1 is triggered by DNA damage and its excessive activation has been proposed as a causative factor in many pathological conditions including ischemia and reperfusion injury, asthma-related inflammation, and atherogenesis.
-
Senaparib
Senaparib is a novel highly potent and selective oral PARP1/2 inhibitor with strong antitumor activity.
Cart
sales@molnova.com